Richard Quinn

Richard Quinn is an award-winning journalist with 15 years’ experience. He has worked at the Asbury Park Press in N.J. and The Virginian-Pilot in Norfolk, Va., and currently is managing editor for a leading commercial real estate publication. His freelance work has appeared in The Jewish State, The Hospitalist, The Rheumatologist, ACEP Now and ENT Today. He lives in New Jersey with his wife, new son and three cats.

Articles by Richard Quinn

Long Delays for Appointments Underscore Need for More Rheumatologists

Richard Quinn | August 1, 2014

Patient access to rheumatologists a serious concern in rural and underserved U.S. communities

Backlog Slows Medicare Appeals Process for Hospitals, Physicians

Richard Quinn | July 11, 2014

Recovery Audit Program brings in record number of appeals, clogs system

Medical Marijuana Use by Rheumatology Patients Needs Closer Look

Richard Quinn | June 20, 2014

Study calls for more research into drug’s safety, side effects before rheumatologists prescribe pot to patients with chronic pain

Hospitalists Gain Insight on Signs, Symptoms of Infection Among Inpatients on Biologic Drugs

Richard Quinn | June 6, 2014

Rheumatologist at Society of Hospital Medicine conference provides treatment recommendations for hospital patients with rheumatic disease

Closer Scrutiny of Chronic Pain Patients Needed

Richard Quinn | May 16, 2014

A new study links high costs to patients with chronic pain conditions and an opioid prescription.

Improved Survival Odds Following Hip & Knee Replacements

Richard Quinn | May 8, 2014

Decreases in mortality rates following elective hip and knee replacement surgeries since 2004 may be partly due to modern surgical techniques and better pre- and post-op care.

Synthetic Hydrogel (aka Squishy Gel) Could Revolutionize Arthritis Treatment

Richard Quinn | April 8, 2014

Squishy gel could include a chemical compound capable of helping repair, restore or regenerate cartilage in a joint.

TNF Inhibitors & RA

Richard Quinn | March 24, 2014

Anti-tumor necrosis factor agents may have cardioprotective effects in rheumatoid arthritis patients

Approval Expected for Apremilast

Richard Quinn | March 5, 2014

New drug shows promise in treating psoriatic arthritis, ankylosing spondylitis & psoriasis

Glaxo’s Move on Physician Compensation Could Signal Shift in Pharmaceutical Promotions

Richard Quinn | February 14, 2014

GlaxoSmithKline has decided to stop paying physicians to promote its products and to cease tying sales-representative compensation to the number of prescriptions physicians write. (posted Feb. 14)